Health
Australian-led international study: Full-dose blood thinners benefit moderately ill COVID-19 patients – Monash University
Full-dose anticoagulation with the blood thinner heparin improves survival outcomes and reduces the need for vital organ support…
05 August 2021
Full-dose anticoagulation with the blood thinner heparin improves survival outcomes and reduces the need for vital organ support such as mechanical ventilation in moderately ill COVID-19 patients, but does not yield the same positive outcomes…
Continue Reading
-
Noosa News18 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News16 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News23 hours agoBrisbane news live: Federal fund for council’s cyclone clean-up dries up
-
Noosa News17 hours agoGood character references restricted in rape cases in Queensland